Cellebrite DI (CLBT) Free Cash Flow (2020 - 2025)

Cellebrite DI's Free Cash Flow history runs 6 years deep, the most recent figure standing at $90.8 million for Q4 2025.

• On a quarterly basis, Free Cash Flow rose 31.27% year-over-year to $90.8 million in Q4 2025; TTM through Dec 2025 was $186.8 million, a 32.71% increase from a year earlier, with the FY2025 full-year figure at $160.3 million, up 21.61% from the prior year.
• Free Cash Flow climbed to $90.8 million in Q4 2025 per CLBT's latest filing, from $36.6 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $90.8 million in Q4 2025 and bottomed at -$10.7 million in Q1 2022.
• The 5-year median for Free Cash Flow is $20.3 million (2023), against an average of $24.6 million.
• Across the five-year window, Free Cash Flow plunged 3592.04% in 2022 and surged 4865.35% in 2023, its largest moves.
• Year by year, Free Cash Flow stood at $29.0 million in 2021, then advanced by 27.86% to $37.1 million in 2022, then advanced by 24.11% to $46.1 million in 2023, then soared by 50.03% to $69.1 million in 2024, then soared by 31.27% to $90.8 million in 2025.
• Per Business Quant, the three latest CLBT Free Cash Flow figures stand at $90.8 million (Q4 2025), $36.6 million (Q3 2025), and $36.2 million (Q2 2025).